Micromet Inc

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	46
ISBN Number	not applicable
Product Code	DAT11475

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

Micromet's main focus is to develop and commercialize products for the treatment of cancer and inflammatory and autoimmune diseases. The company continues to leverage the capability for their early-stage development collaborations as well as for generating additional product candidates for its own pipeline, especially new product candidates based on its proprietary BiTE development platform.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Micromet is a biopharmaceutical company focused on developing of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases. Micromet uses its BiTE technology primarily to advance its own internal development activities. The company also leverages it broadly through licenses and collaborations so that other biopharmaceutical and pharmaceutical companies can use it to discover and develop biopharmaceutical leads. Micromet currently does not market any drugs. Substantially all of the company's revenues come from licensing, funded research and development activities including milestone payments from its licensees and collaborators. Micromet's total revenues increased at a CAGR of 67% during 2002-2006, from $4 million to $28 million.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Micromet - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table of Tables
- Table 1: Micromet - Key Facts
- Table 2: Micromet - Locations and Subsidiaries
- Table 3: Micromet - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 4: Micromet - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 5: Micromet - Balance Sheet, 2002-2006 ($ Mn)
- Table 6: Micromet - Cash Flow, 2002-2006 ($ Mn)
- Table 7: Micromet - in-House Pipeline Products
- Table 8: Micromet - Collaboration Pipeline Products
- Table 9: Micromet - Forecast Sales, 2006-2010 ($ Mn)
- Table 10: Micromet - Key Competitors
- Table 11: Micromet - Key Suppliers
- Table 12: Micromet - Key Clients
- Table 13: Micromet - Key Shareholders
- Table 14: Micromet - SWOT Analysis Summary
- Table 15: Micromet - Value Chain Analysis
- Table 16: Micromet - Scorecard
- Table 17: Micromet - Key Employees
- Table 18: Micromet - Financial and Operational Overview